InVision Medical Technology
InVision Medical Technology develops AI tools to streamline the interpretation of heart ultrasounds, aiming to identify undiagnosed heart disease. With 32 million ultrasound examinations performed annually in the U.S., their technology addresses the significant time burden on physicians and technicians, enhancing efficiency and accuracy in cardiac diagnostics. The company has received FDA clearance and breakthrough device designation for its innovative solutions, positioning itself as a leader in AI-driven cardiac care.
InVision Medical Technology
InVision Medical Technology develops AI tools to streamline the interpretation of heart ultrasounds, aiming to identify undiagnosed heart disease. With 32 million ultrasound examinations performed annually in the U.S., their technology addresses the significant time burden on physicians and technicians, enhancing efficiency and accuracy in cardiac diagnostics. The company has received FDA clearance and breakthrough device designation for its innovative solutions, positioning itself as a leader in AI-driven cardiac care.
TL;DR
Headquarters: Los Angeles, California
Product: AI software for echocardiography (LVEF quantification, cardiac amyloidosis detection)
Regulatory: FDA 510(k) clearance and Breakthrough Device designation
Backers: Backed by Y Combinator
Company Overview
Problem Domain
Cardiac imaging diagnostics (echocardiography interpretation)
Industry
Medical AI / Healthtech
Funding Track Record
500000.00
Investor Signal
“Backed by Y Combinator”